Search

everythinglearnresearchcommunity

for

Search:↓

JAK inhibitors are more effective and safer for treating alopecia areata than dupilumab and apremilast.

Hair dye ingredient PPD can cause severe allergic reactions, including facial swelling.

In 2021, JAMA Dermatology published significant findings on skin conditions post-COVID vaccination, melanoma surveillance, atopic dermatitis treatments, and confirmed that sun protection does not harm bone health.

JAM-A modification speeds up skin wound healing by boosting fibroblast growth.

A 15-year-old with KID syndrome developed a rare skin condition called PEHFN.

DCPA is a chronic leg infection often related to Staphylococcus aureus, affecting mostly young men in India.

Plantago asiatica L. extract can promote hair growth by enhancing the anagen phase.

A specific gene change is linked to severe hair loss.

Japanese patients and physicians often disagree on the severity of Alopecia Areata and treatment satisfaction, needing better communication and treatments.

The new tool helps measure the impact of alopecia areata on children's quality of life.

The new patient-controlled expansion technique for breast reconstruction is safe, efficient, and cost-effective.

Oral JAK inhibitors improved alopecia areata by modulating immune responses and boosting hair growth.

AUC and APL are distinct conditions needing careful clinical assessment.

JAK inhibitors effectively reduce alopecia areata symptoms in Black patients.

Annurca apple extract promotes hair growth by changing hair follicle metabolism to boost keratin production.

Early diagnosis of Keratosis pilaris atrophicans faciei can lead to better, personalized treatments.

The study developed a mouse model for Alopecia Areata that responds to treatment, useful for future research.

Pediatric alopecia areata is more immune-active than adult cases, suggesting age-specific treatments and potential use of JAK inhibitors.

PRAME helps distinguish between benign and malignant skin cells in most cases.

A new method effectively detects toxic pyrrolizidine alkaloids in honey and flour.

The treatment increased total hair count but wasn't significantly better than placebo.

Upadacitinib significantly improved both rheumatoid arthritis and alopecia areata in a patient.

PPAR-γ may be a key target for treating alopecia areata and other skin conditions.

The document's conclusion cannot be provided because the document is not accessible or understandable.

Janus kinase inhibitors are promising for treating scarring alopecia, but more research is needed for safety and personalized treatments.